ArticleScience translational medicine2022

Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma.

Shivendra Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.